About 25,000 new cases of ovarian cancer are diagnosed annually in the US. It is frequently undiagnosed until it has spread. The lifetime risk for developing the disease is % and risk factors include a family history of the condition, age, obesity, history of breast cancer and hormone replacement therapy. A new report in the Archives of Internal Medicine claims that oral hormone therapy does increase the risk of ovarian cancer in women who have not had a hysterectomy. It is the estrogen component of the hormone therapy that increases the risk and not the progesterone component. It was also found that the risk was associated with the cumulative oral estrogen intake and not the length of time the hormone therapy has been taken. Thus, it is advisable to aim to reduce daily estrogen intake as much as possible in order to reduce the risk of ovarian cancer.
Source: summary of medical news story as reported by Cancer Consultants
About: Hormone therapy associated with increased risk of ovarian cancer
Date: 10 January 2005
Source: Cancer Consultants
URL:
http:/ This summary article refers to the following medical categories:
What do you think about the features of this website?
Take our user survey and have your say:
Tools & Services:
Medical Articles:
Related Medical Topics
» Next page: Hormone therapy may prevent many premature births
Rate This Website
Medical Tools & Articles:
Forums & Message Boards
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
